Email updates

Keep up to date with the latest news and content from BMC Bioinformatics and BioMed Central.

This article is part of the supplement: UT-ORNL-KBRIN Bioinformatics Summit 2009

Open Access Meeting abstract

Transcriptional profiling of CD4 T-lymphocytes reveals abnormal gene expression in young prediabetic NOD mice

Dorothy N Kakoola, Nataliya I Lenchik, Anita Curcio-Brint and Ivan C Gerling*

Author affiliations

Department of Medicine, University of Tennessee Health Science Center and Research Service, Veterans Affairs Medical Center, Memphis, TN 38104, USA

For all author emails, please log on.

Citation and License

BMC Bioinformatics 2009, 10(Suppl 7):A15  doi:10.1186/1471-2105-10-S7-A15

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2105/10/S7/A15


Published:25 June 2009

© 2009 Kakoola et al; licensee BioMed Central Ltd.

Background

CD4 T-lymphocytes play a prominent role in Type 1 DM. The NOD mouse is a model for this autoimmune disease. The earliest histological signs of autoimmunity in female NOD mice occur at approximately 5 weeks of age. We hypothesized that this process may be preceded by molecular events in the CD4 T-lymphocytes. To test this hypothesis, we analyzed the transcriptomes of CD4 T-lymphocytes of young "prepathologic" NOD mice.

Methods

Using a magnetic separation system (Miltenyi Biotec), we isolated CD4 T-lymphocytes from spleen leukocytes of female NOD mice, and two control strains, NOR and C57Bl/6, at 2, 3, and 4 weeks of age (n = 5 for each strain, except for NOD 2 wk where n = 4). CD4 T-lymphocyte transcriptomes were characterized on Affymetrix Mouse 430_2 expression arrays probing ~39,000 mouse genes/ESTs. Gene lists produced from statistical analyses were mined using Ingenuity Pathway Analysis http://www.ingenuity.com webcite.

Results

Analysis by 1-way ANOVA (p < 0.005, Benjamin-Hochberg Multiple Test Correction (MTC) defined 311, 624, and 581 probesets (genes) with highly significant expression differences between strains at 2, 3 and 4 weeks, respectively. Hierarchical clustering of these probeset lists identified 58, 115, and 65 probesets, respectively for 2, 3, and 4 week old mice, as being differentially expressed in NOD mice relative to both control strains (17, 32, and 9 were upregulated in NOD mice while 41, 83, and 56 were downregulated). Pathway analysis of the 3 gene lists (58, 115 and 64 probesets) revealed that 7 (HNF4A, IFNG, IL4, TP53, BCL2L1, IL15, and prostaglandin E2) of the top 15 central genes in each network were common to all age groups. IL6 was central in networks of 2 and 4 week old mice but not of 3 week old mice. Uniquely central to individual networks were: MYC, JUN and HRAS at 2 weeks; TNF, NFKB, p38MAPK, and TGFB1 at 3 weeks; and Interferon alpha, IL12 and STAT4 at 4 weeks.

Conclusion

We conclude that young, prediabetic NOD mice have basic (i.e. common, most likely genetic) molecular defects in CD4 T-cells associated with apoptosis/cellular proliferation, Th1-Th2 differentiation and cytokine signaling. Furthermore, abnormalities in apoptosis/cellular proliferation predominate at 2 weeks of age while those in cellular activation/acute phase response signaling and inflammation predominate in 3 week old mice. Finally, abnormalities in the innate immune response and its link to the adaptive immune response are evident at 4 weeks of age.

Acknowledgements

This work was supported by a research supplement grant from the National Institute of Diabetes & Digestive & Kidney Diseases, DK062103.